Laksh Aithani

Laksh Aithani Email and Phone Number

Founder, CEO and Board Member at CHARM Therapeutics @ CHARM Therapeutics
Laksh Aithani's Location
London, England, United Kingdom, United Kingdom
Laksh Aithani's Contact Details

Laksh Aithani personal email

n/a
About Laksh Aithani

Passionate about drug discovery and machine learningAngel investments- T-Therapeutics (F-Prime, Sofinnova)- Chemify (DCVC, Founders Fund, Triatomic)- Replay Bio (KKR, Artis)- Latent Labs (Kindred, 8VC)- Axiom Bio (Amplify Partners)- Iconic AI (HodlCo)- Scale Medicine (Lux)

Laksh Aithani's Current Company Details
CHARM Therapeutics

Charm Therapeutics

View
Founder, CEO and Board Member at CHARM Therapeutics
Laksh Aithani Work Experience Details
  • Charm Therapeutics
    Founder, Ceo And Board Member
    Charm Therapeutics Oct 2021 - Present
    London, Gb
    View
  • Braavos Investment Advisers
    Venture Partner
    Braavos Investment Advisers 2021 - Present
    Braavos Investment Advisers is a £300M venture capital fund committed to backing ambitious founders building scientific companies in the UK, with a particular focus on Oxford. Please reach out if you're a founder who fits in this bucket (laithani@braavos.uk)
    View
  • Genei
    Founder (Y-Combinator Backed)
    Genei 2018 - Present
    London, England, Gb
    Founded my first company during university: an AI web tool to enable researchers to research faster. Backed by Y-Combinator and raised a seed roundTry it: genei.io
    View
  • Exscientia
    Machine Learning Engineer
    Exscientia 2019 - 2021
    Oxford, Oxfordshire, Gb
    Exscientia (NASDAQ: EXAI) applies artificial intelligence (AI) to drug discovery, enabling faster progression of candidates into the clinic. They have raised over $675M in venture capital funding to date and have advanced 1 majority-owned asset into the clinic, a brain-inpenetrant A2A antagonist that reverses immune suppresion in adenosine-rich tumour micro-environments.Contributions:- Scientific and engineering development of the predictive modeling platform. - Lead development of the automated human dose prediction platform, and deployment onto live immuno-oncology and autoimmune discovery projects.- Discovery of bispecific hits for an undisclosed neuroscience target.- Authorship on a publication involving the ML-guided development of malaria therapeutics.Learnings:- Witnessing of headcount tripling to 120+ in <2 years ("blitzscaling")- Practical drug discovery- Cloud computingInternship followed by full-time role.
    View

Laksh Aithani Skills

Microsoft Office Research Python Java Microsoft Excel Leadership Microsoft Word Project Management Microsoft Powerpoint Strategic Planning Html5 Python Amazon Web Services

Laksh Aithani Education Details

  • University Of Cambridge
    University Of Cambridge
    Natural Sciences

Frequently Asked Questions about Laksh Aithani

What company does Laksh Aithani work for?

Laksh Aithani works for Charm Therapeutics

What is Laksh Aithani's role at the current company?

Laksh Aithani's current role is Founder, CEO and Board Member at CHARM Therapeutics.

What is Laksh Aithani's email address?

Laksh Aithani's email address is la****@****a.co.uk

What schools did Laksh Aithani attend?

Laksh Aithani attended University Of Cambridge.

What skills is Laksh Aithani known for?

Laksh Aithani has skills like Microsoft Office, Research, Python, Java, Microsoft Excel, Leadership, Microsoft Word, Project Management, Microsoft Powerpoint, Strategic Planning, Html5, Python.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.